Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.5900 (0.76%) ($67.5900 - $67.6400) on Tue. Aug. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.13% (three month average) | RSI | 50 | Latest Price | $67.5900(0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) SMH(75%) IVW(64%) XBI(54%) IBB(47%) XHB(45%) | Factors Impacting LGND price | LGND will decline at least -1.065% in a week (0% probabilities). TBT(-29%) VXX(-24%) UUP(-23%) URA(-12%) XLU(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.065% (StdDev 2.13%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $68.36(-1.13%) | 10 Day Moving Average | $67.49(0.15%) | 20 Day Moving Average | $67.38(0.31%) | To recent high | -15.1% | To recent low | 2.1% | Market Cap | $1.086b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |